A new editorial paper was published in Oncotarget’s Volume 14 on June 12, 2023, entitled, “ERβ as a mediator of estrogen signaling in inflammatory breast cancer.”
Molecular Devices opens custom-built site in Cardiff for manufacturing of patient-derived organoids
Today, Molecular Devices, LLC., a leading high-performance life science solutions provider, officially opened its custom-built site in Cardiff, UK.